Shimizu Hisaka, Nakajima Masahiro, Miyanaga Akimasa, Takahashi Yuta, Tanaka Nobukiyo, Kobayashi Kaito, Sugimoto Naohisa, Nakai Hiroyuki, Taguchi Hayao
Department of Applied Biological Science, Faculty of Science and Technology , Tokyo University of Science , 2641 Yamazaki , Noda , Chiba 278-8510 , Japan.
Department of Chemistry , Tokyo Institute of Technology , 2-12-1, O-okayama , Meguro-ku, Tokyo 152-8551 , Japan.
Biochemistry. 2018 Jul 3;57(26):3849-3860. doi: 10.1021/acs.biochem.8b00385. Epub 2018 May 25.
β-1,2-Glucan is a polysaccharide produced mainly by some Gram-negative bacteria as a symbiosis and infectious factor. We recently identified endo-β-1,2-glucanase from Chitinophaga pinensis ( CpSGL) as an enzyme comprising a new family. Here, we report the characteristics and crystal structure of a CpSGL homologue from Parabacteroides distasonis, an intestinal bacterium (BDI_3064 protein), which exhibits distinctive properties of known β-1,2-glucan-degrading enzymes. BDI_3064 hydrolyzed linear β-1,2-glucan and β-1,2-glucooligosaccharides with degrees of polymerization (DPs) of ≥4 to produce sophorose specifically but did not hydrolyze cyclic β-1,2-glucan. This result indicates that BDI_3064 is a new exo-type enzyme. BDI_3064 also produced sophorose from β-1,2-glucooligosaccharide analogues that have a modified reducing end, indicating that BDI_3064 acts on its substrates from the nonreducing end. The crystal structure showed that BDI_3064 possesses additional N-terminal domains 1 and 2, unlike CpSGL. Superimposition of BDI_3064 and CpSGL complexed with ligands showed that R93 in domain 1 overlapped subsite -3 in CpSGL. Docking analysis involving a β-1,2-glucooligosaccharide with DP4 showed that R93 completely blocks the nonreducing end of the docked β-1,2-glucooligosaccharide. This indicates that BDI_3064 employs a distinct mechanism of recognition at the nonreducing end of substrates to act as an exo-type enzyme. Thus, we propose 2-β-d-glucooligosaccharide sophorohydrolase (nonreducing end) as a systematic name for BDI_3064.
β-1,2-葡聚糖是一种主要由某些革兰氏阴性菌产生的多糖,作为共生和感染因子。我们最近从食几丁质菌(CpSGL)中鉴定出内切β-1,2-葡聚糖酶,它是一个新家族的酶。在此,我们报告了来自肠道细菌狄氏副拟杆菌的一种CpSGL同源物(BDI_3064蛋白)的特性和晶体结构,该蛋白表现出已知β-1,2-葡聚糖降解酶的独特性质。BDI_3064水解聚合度(DP)≥4的线性β-1,2-葡聚糖和β-1,2-葡萄糖寡糖,特异性产生槐糖,但不水解环状β-1,2-葡聚糖。这一结果表明BDI_3064是一种新型外切型酶。BDI_3064还能从具有修饰还原端的β-1,2-葡萄糖寡糖类似物中产生槐糖,表明BDI_3064从非还原端作用于其底物。晶体结构显示,与CpSGL不同,BDI_3064具有额外的N端结构域1和2。将BDI_3064与结合配体的CpSGL进行叠加显示,结构域1中的R93与CpSGL中的亚位点-Ⅲ重叠。涉及DP4的β-1,2-葡萄糖寡糖的对接分析表明,R93完全阻断了对接的β-1,2-葡萄糖寡糖的非还原端。这表明BDI_3064在底物的非还原端采用独特的识别机制,从而作为外切型酶发挥作用。因此,我们提议将2-β-D-葡萄糖寡糖槐糖水解酶(非还原端)作为BDI_3064的系统名称。